As of May 27
| +1.20 / +5.17%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 28.50, with a high estimate of 38.00 and a low estimate of 18.00. The median estimate represents a +16.85% increase from the last price of 24.39.
The current consensus among 4 polled investment analysts is to Hold stock in Enanta Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.